On-Demand

Beyond the Pillbox: HOPE, Hospice Meds & Symptom Monitoring

Managing pain and preventing unnecessary suffering are at the heart of hospice care—and the HOPE assessment sharpens our ability to do both. This webinar will focus on Section N of the HOPE assessment, which captures key data on scheduled and PRN opioid use, as well as bowel regimens to prevent opioid-induced constipation. We’ll explore how this data, along with symptom impact and pain screening items, drives effective care planning and supports holistic, patient-centered care.

In addition, we’ll connect HOPE guidance with the Hospice Conditions of Participation (CoPs) related to medication management and symptom control, reinforcing how regulatory compliance can enhance quality of life. Join us as we translate assessment data into meaningful, compassionate care delivery.

Watch On-Demand

Fill out the form to watch this on-demand webinar

Meet the presenters

Dee Geray

Senior Manager, Clinical Consulting Services, McBee

Michelle Horner

Manager, Clinical Consulting & Education, McBee

What you'll learn in this webinar

Identify the HOPE Section N items related to scheduled opioids, PRN opioids and bowel regimens, and explain their role in guiding holistic symptom management.
Describe the clinical rationale behind monitoring opioid use and implementing prophylactic bowel regimens to prevent opioid-induced constipation.
Examine how the HOPE assessment connects symptom impact data—such as pain and constipation—with care planning and SFV (Symptom Follow-Up) visits.
Interpret relevant Hospice Conditions of Participation (CoPs) related to medication and symptom management, and how they support patient-centered care delivery.
Apply strategies to align documentation, medication oversight and symptom relief efforts with HOPE and regulatory expectations.

Want to connect with Netsmart?

See why community-based providers choose Netsmart for their health IT needs. Get a free demo of our software in action.